Martin LeBlanc

Business Development Officer

Joined RSI in 2019

  • Country of Residence

Martin LeBlanc

Personal Introduction

I started in the work force as an electrical/mechanical technician putting together robotic assembly lines and automated systems. Once a system was ready to run, it was amazing to see the work that could be done with just a few motors, control systems and mechanical assemblies. Just as fascinating was to see how quickly things can go wrong, indeed the devil is in the details. These first experiences demystified the magic of modern machinery and really piqued my interest in the field. This led to a position with a large national print shop, originally engage to support the installation of two robotic lines. My scope quickly broadened to take on various production and health and safety improvement projects in the development of software tools (automate print layout formatting, various machine to system communication interfaces, and automation system simulations), machine design and implementation ( robotic manipulation components, automated conveyer systems with multiple inputs, automated multi-step production lines, and ad-hoc conveying solution to bridge the gap of a new installation) and several hazard identification and ergonomic assessments (design, build and implement safer access devices, access platforms, and work surfaces). Overall, I enjoyed getting multiple elements together to make a project happen.

Changing gears somewhat, I was introduced into sales through the staffing and recruiting industry. I was quick to jump into this line of work, having worked along side the technical and engineering positions I would be sourcing for. I staffed positions across Canada and internationally for anything that was technical in and nature and senior executive positions. Certainly, a change of pace to all the machine noise I had been accustom to, I started bringing in my own clients and began getting involved in government procurement. I then took a position with a consulting firm that specialized in nuclear safety. The focus in this role resembles that of which I have today: assessing opportunities, responding to them as appropriate, and assembling project teams. I was involved in several multi-year proposal submissions and wins for national and international government organizations.

Martin LeBlanc: Current Focus

Mr. Martin LeBlanc is responsible for growing RSI’s book of business, supporting all activities to this end. His line is always open to assist clients old and new. He strives to understand and provide a client’s unique need on a project, having done so for many government and private clients across the health, nuclear, power generation, aerospace, manufacturing, transportation and national defence sectors. As needed, he will seek out and qualify partnering firms, independent contracts and additional staff, handling agreement review and development along with contract negotiation. Mr. LeBlanc casts a broad net in identifying new opportunities and conducts the initial competitive tender feasibility assessment. He brings proposals of varying complexity from cradle to contract developing the initial project outline according to proposal strategy constraints.

Many clients require the use of their formal procurement processes to contract vendor services. Martin is well versed in vendor procurement, formal bidding processes and the intricacies that accompany. He regularly responds to Government of Canada (GoC), Canada wide provincial, crown corporation and private organization procurement requests with a compliant submission. He has a broad knowledge of the limits and constraints of the more common GoC procurement vehicles, one-off organization specific standing offers, supply arrangements while staying current with their ever-changing policies. Mr. LeBlanc regularly pursues international projects and is a quick study when engaging in a new procurement process.

Works and Accomplishments

Developed or supported contracts with:

  • Canadian Federal Departments (i.e. Department of National Defence, Health Canada, Public Health agency of Canada, Canadian Nuclear Safety Commission, Public Service and Procurement Canada)
  • Provincial and Federal Crown Corporations
  • International Organizations (i.e. United Nation Organizations, other private organizations)
Please enter your name.
Please enter a subject.
Please enter a message.
Please check the captcha to verify you are not a robot.
  • 0%

    99% of our added value is our staff.

RSIepidemiologiststoxicologistsmedical doctorsengineersprogrammerssoftware engineerseditorstranslatorscampaignerscommunicatorsperception analystspolicy expertsregulatory advisorschemistsbiologistsclimate expertsurban expertspublic health specialistsmathematicianstrainers

Nataliya Karyakina

Dr. Nataliya Karyakina has solid knowledge and extensive experience in hazard identification and human health risk assessments of toxic chemicals present in air, water, food and consumer products. Her research focuses on multidisciplinary studies of potential adverse health effects.

Full Bio...

Greg Paoli

As RSI’s Principal Risk Scientist and COO, Greg Paoli is currently working with a broad spectrum of clients in the public and private sectors, with the greatest emphasis on the development of new approaches to transform regulatory systems to be more “risk-based” at multiple levels: how senior decision-makers process risk information and make the “tough choices” in regulating health and safety, how an organization can optimize its resources across a diverse mandate to maximize total “portfolio-level” risk reduction, and how to operationalize key resources like the scheduling of inspections when faced with thousands of inspection targets, but not enough resources to inspect all of them.

Full Bio...

Emma Hartnett

Dr. Hartnett currently works on the development of risk-based decision-making processes and tools to support public risk assessment. Current focus includes: working with the Canadian Food Inspection Agency exploring methodologies to support risk-based monitoring of contaminants in food; working with Transport Canada to develop guidelines and methodologies to support risk-based decisions related to public risks from the transportation system; working with the U.S. Food and Drug Administration on continuing expansions and improvements to the FDA-iRISK tool.

Full Bio...

Anne Wiles

For her work at RSI, Anne has built on her previous experience and academic research through work on communication on nuclear power and nuclear waste disposal; developing communication strategies and messaging on health risk issues; and delivering training on risk communication. She has also applied her familiarity with risk regulation in many projects on government…

Full Bio...

Hong Duan

Since joining RSI’s technical team in 2011, Hong has focused on developing risk-based database-driven web projects. Her extensive knowledge and experience, has helped RSI to develop high quality software for multiple clients including the Public Health Agency of Canada, the U.S. Food and Drug Administration, the Food and Agriculture Organization of the United Nations based in Rome, and the World Health Organization based in Geneva.

Full Bio...

Michael G. Tyshenko

Dr. Tyshenko is involved with various health risk issues and is the lead on chemical peer reviews at RSI. He continues international research on infectious disease health policy and evidence-based decision-making for SARS, MERS and COVID-19 with a collaborative working group from China, USA, and the UAE. Other ongoing work in Nepal with the Ministry of Health in collaboration…

Full Bio...

Daniel Krewski

Dr. Krewski serves as Chief Risk Scientist and CEO of Risk Sciences International. He also holds academic appointments as Professor in the School of Epidemiology and Public Health and Scientific Director of the McLaughlin Centre for Population Health Risk Assessment in the Faculty of Medicine at the University of Ottawa. Dr. Krewski is a Fellow of the Society of Risk Analysis and the American Statistical Association, and a lifetime National Affiliate of the US National Academy of Sciences. In 2013, he received the Distinguished Achievement Award from the Society for Risk Analysis, for excellent performance in the practice of risk analysis. He has contributed to over 900 scientific and technical publications in the field of risk science during the course of his career to date.

Full Bio...

Siva Ramoju

Siva Ramoju holds Masters Degrees in Biotechnology as well as Cellular Toxicology. His previous and present work in cellular toxicology has provided him with training and research experience in understanding how chemicals can damage individual cells, and an understanding of toxicity from the perspective of the whole animal.

Full Bio...

Cemil ‘Jim’ Alyanak

Now serving as RSI’s Vice-President Communications and Strategic Initiatives, for years Cemil has provided organizations with guidance designed to transmit mission-critical messages. An anti-tobacco campaign is not about promoting a strategy, it’s about saving lives. Get the message wrong and people die. That type of commitment to results is what Cemil brings to Risk Sciences International.

Full Bio...

Franco Momoli

Dr. Momoli is the acting Practice Lead for Chemical and Product Safety at Risk Sciences International, as well as an adjunct professor in the School of Epidemiology and Public Health at the University of Ottawa.

Full Bio...

Donald Mattison

Dr. Donald Mattison was appointed Chief Medical Officer and Senior Vice President of Risk Sciences International in 2012. Dr. Mattison also serves as Associate Director of the McLaughlin Centre for Population Health Risk Assessment and as Adjunct Professor at the School of Epidemiology and Public Health at the University of Ottawa. He is also Medical Advisor to QuarterWatch: Monitoring FDA MedWatch Reports published by the Institute for Safe Medication Practices in Horsham, Pennsylvania.

Full Bio...

Todd Ruthman

Todd Ruthman’s current focus is on tools that help regulators visualize and understand the public risk burden within their mandates to help inform risk-based decisions. Mr. Ruthman provides design, management, modelling, coding, and database development expertise for these tools. Mr. Ruthman also manages the RSI development group enhancing previously released tools…

Full Bio...

Natalia (Natasha) Shilnikova

At RSI, Dr. Natalia (Natasha) Shilnikova has been working on projects involving toxicology, epidemiology and human health risk assessment, such as development of toxicity profiles for several chemicals on Health Canada’s Domestic Substances List (DSL); a systematic review of potential cancer and reproductive risks of artificial sweeteners for the International…

Full Bio...

Jennifer Go

Jennifer joined RSI in August of 2017 as a Risk Analyst with specialization in epidemiology. She possesses a diverse set of skills that contributes to her flexibility to work on a wide range of scientific projects. In particular, Jennifer has research experience in programming using SAS, manipulating large datasets, constructing statistical models, interpreting quantitative data, …

Full Bio...